These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26368923)

  • 1. Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme.
    Lee J; Narang S; Martinez J; Rao G; Rao A
    PLoS One; 2015; 10(9):e0136557. PubMed ID: 26368923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
    Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
    Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of graph-based spatial features with overall survival status of glioblastoma patients.
    Lee J; Narang S; Martinez J; Rao G; Rao A
    Sci Rep; 2023 Oct; 13(1):17046. PubMed ID: 37813981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.
    Hu X; Wong KK; Young GS; Guo L; Wong ST
    J Magn Reson Imaging; 2011 Feb; 33(2):296-305. PubMed ID: 21274970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating spatial diversity features of radiologically defined tumor habitats with epidermal growth factor receptor driver status and 12-month survival in glioblastoma: methods and preliminary investigation.
    Lee J; Narang S; Martinez JJ; Rao G; Rao A
    J Med Imaging (Bellingham); 2015 Oct; 2(4):041006. PubMed ID: 26835490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
    Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
    J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.
    Mangla R; Singh G; Ziegelitz D; Milano MT; Korones DN; Zhong J; Ekholm SE
    Radiology; 2010 Aug; 256(2):575-84. PubMed ID: 20529987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.
    Stringfield O; Arrington JA; Johnston SK; Rognin NG; Peeri NC; Balagurunathan Y; Jackson PR; Clark-Swanson KR; Swanson KR; Egan KM; Gatenby RA; Raghunand N
    Tomography; 2019 Mar; 5(1):135-144. PubMed ID: 30854451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
    Chaddad A; Sabri S; Niazi T; Abdulkarim B
    Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
    Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
    Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
    Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
    Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.
    Dextraze K; Saha A; Kim D; Narang S; Lehrer M; Rao A; Narang S; Rao D; Ahmed S; Madhugiri V; Fuller CD; Kim MM; Krishnan S; Rao G; Rao A
    Oncotarget; 2017 Dec; 8(68):112992-113001. PubMed ID: 29348883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
    Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
    J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.
    Schmainda KM; Zhang Z; Prah M; Snyder BS; Gilbert MR; Sorensen AG; Barboriak DP; Boxerman JL
    Neuro Oncol; 2015 Aug; 17(8):1148-56. PubMed ID: 25646027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma.
    Akbari H; Macyszyn L; Da X; Bilello M; Wolf RL; Martinez-Lage M; Biros G; Alonso-Basanta M; OʼRourke DM; Davatzikos C
    Neurosurgery; 2016 Apr; 78(4):572-80. PubMed ID: 26813856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor shape features for overall survival prognosis in glioblastoma multiforme patients.
    Sanghani P; Ti AB; Kam King NK; Ren H
    Surg Oncol; 2019 Jun; 29():178-183. PubMed ID: 31196485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.